Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 21 results for "drl"

DRL gets 3 USFDA observations for Miryalaguda facility

, an integrated global pharmaceutical company, announced that the audit of the company's API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017. The company have been issued a Form 483 with three observations, which the ... Myiris, 2 days ago

76 images for drl

Money Control, 1 week ago
Money Control, 1 week ago
Rush Lane, 2 weeks ago
Rush Lane, 3 weeks ago
Industrial Equipment News, 4 weeks ago
Industrial Equipment News, 4 weeks ago
ForceGT, 3 weeks ago
ENCA, 4 weeks ago
Funky Kit, 4 weeks ago
Before It's News, 1 month ago
Money Control

DRL says no claims for monetary damages in US patent case

Drug major Dr Reddy's Laboratories today said there are no claims against the company for monetary damages after it received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.
 DNA1 week ago DRL gets adverse ruling in US over patent infringement case  DNA1 week ago

Sensex, Nifty, Midcap continue to gain; ICICI leads, DRL drags

ICICI Bank was biggest gainer among Sensex stocks, up 2.5 percent followed by ITC, HDFC, HDFC Bank, SBI, LT, Axis Bank and Reliance Industries.
 Money Control2 weeks ago
Money Control

Top buzzing stocks to trade on January 12

Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.
 Money Control1 month ago

Sensex, Nifty, Midcap jump over 1%; Tata Motors zooms, DRL down

Equity benchmarks as well as broader markets climbed over a percent in morning trade, driven by positive global cues. Even the withdrawal of incremental CRR hike boosted the sentiment further.
 Money Control2 months ago

DRL to resume growth path in FY18 with 15 'significant' launches

Saumen Chakraborty, CFO of Dr Reddy's is confident of getting back on to the growth path starting FY18 on the back of more than 15 significant launches and approvals that will help the pharma major make a comeback.
 Money Control2 weeks ago
Business Standard

Honda launches fourth generation 'Honda City 2017' from Rs. 8.49 lakh onwards

Japanese car maker Honda on Tuesday unveiled its fourth generation 'Honda City 2017' that has stylish and sporty exterior designs with enhanced safety features and advanced high tech infotainment system with price starting from Rs. starting from Rs. 8.49 lakh ...
 Business Standard1 week ago
DNA

Dr Reddy's Lab Q3 net profit dips 19% to Rs 470 crore

Dr Reddy's Laboratories today said its net profit for the December quarter was down by 19 per cent to Rs 470 crore (as per IFRS) against Rs 579 crore during the corresponding quarter in FY16 owing to drop in North American sales. Saumen Chakraborty, ...
 Business Standard2 weeks ago Dr Reddy's net profit drops by 19% to Rs 470 crore  DNA2 weeks ago Dr Reddy's Laboratories retreats after rallying from lower levels  Sify2 months ago

Sensex Trades on a Positive Note; Power Stocks Gain

Posted by Equitymaster After opening the day in the green, the Indian share markets have continued to trade strong and are currently trading above the dotted line. With the exception of stocks in the FMCG sector all sectoral indices are trading on a positive ...
 Equitymaster.com4 weeks ago
Rediff.com

Dr Reddy's sued in US court by S Korean pharma co

Suit alleges fraud by hiding significant deficiencies in CGMP regulations enforced by US health regulator. Seoul-based biotech company Mezzion Pharma has filed a suit against Dr Reddy’s Laboratories in a US court. It has alleged the Hyderabad-based supplier had committed fraud by hiding significant deficiencies in the Current Good Manufacturing Practice, or CGMP, regulations enforced by the US health regulator. In the suit, filed in the state of New Jersey, Mezzion seeks to “recover ...
 Rediff.com4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less